Skip to content

To evaluate the efficacy of Phalatrikadi Ghana Vati in Patients of Non-Alcoholic Fatty Liver Disease

Evaluation of efficacy of Phalatrikadi Ghana Vati in patients of Non-Alcoholic Fatty Liver Disease, through reverse pharmacology approach.

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047796
Enrollment
60
Registered
2022-11-30
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

None listed

Sponsors

Dr Piyush Chaudhary
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Ultrasonography (USG) abdomen suggestive of NAFLD with or without symptoms like pain in right upper quadrant/epigastric region of the abdomen, feeling of nausea, and vomiting, loss of appetite, burning sensation in the abdomen. 2.Liver function tests showing raised alanine transaminases (ALT) or aspartate transaminases (AST) levels raised above the normal limits (40IU/L) up to 300 IU/L

Exclusion criteria

Exclusion criteria: 1. Patients unwilling to participate in study 2. Patients with a history of alcohol intake exceeding 20 g/day (Alcohol consumption history shall be separately obtained from the patients and family) 3. Patients testing positive for markers of other viral hepatitis

Design outcomes

Primary

MeasureTime frame
Improvement in symptoms Udarasula (pain in abdomen), utklesa (feeling of nausea and vomiting), agnimandya (impaired digestion), klama (Fatigue), aruci (loss of appetite), sadana (malaise) & Improvement in USG for NAFLD Improvement in BMI, ALT, AST & ALT/AST Ratio & Lipid ProfileTimepoint: baseline And 84 days

Secondary

MeasureTime frame
1. mprovement in symptoms Udarasula (pain in abdomen), utklesa (feeling of nausea and vomiting), agnimandya (impaired digestion), klama (Fatigue), aruci (loss of appetite), sadana (malaise)Timepoint: Baseline, 28th day, 56th day and 84 days

Countries

India

Contacts

Public ContactProf Anil Sharma

Shri Krishna Govt. Ayurveda College

anilherbals@gmail.com9416085092

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026